Broad Institute, Inc.
Cambridge, Massachusetts, United States
Purpose
to better prioritize antimalarial drug candidates by identifying those compounds that inhibit the efficacy of drugs used to treat HIV and tuberculosis (TB) when administered to the same person using an in vitro human microliver model
Division
Global Health
Date
April 2013
Region Served
GLOBAL
Committed amount
$99,951
Grant topic
Discovery and Translational Sciences
Duration (months)
19
Grantee location
Cambridge, Massachusetts, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.